Biography
Marina Sirota is a Professor and Interim Director of UCS Fs Bakar Computational Health Sciences Institute. Previously, she served as a Senior Research Scientist at Pfizer, focusing on precision medicine. She earned her PhD in Biomedical Informatics from Stanford University. With 20 years of experience and over 170 publications, Dr. Sirota develops computational integrative methods for diagnostics and therapeutics, specializing in womens health. Her laboratory is funded by the NIA, NLM, NIAMS, Pfizer, and the March of Dimes. A 2017 A MIA Young Investigator Award recipient, she leads the UCSF March of Dimes Prematurity Research Center and co-directs ENACT, a precision medicine center for endometriosis. Dr. Sirota also founded UCS Fs AI4ALL program, which introduces high school girls to the applications of AI and machine learning in biomedicine.

Biography
Innovative Senior Data Scientist with over 10 years of leadership experience in biomarker discovery, advanced analytics for drug development, clinical data science and AI implementation. Proven expertise in integrating multi-modal data, deploying AI-driven solutions across clinical research environments, and fostering strategic collaborations internally and externally to deliver high-impact results. Recognized for excellence in aligning scientific expertise with business needs to drive actionable insights and improve decision-making. In her current role, she helps Novo Nordisk's longevity task force to understand the longevity potential of its assets, design longevity-focused clinical trials, and engage with regulatory authorities to define longevity outcomes. She also analyses omics data from RCTs to understand drug mode of action and identify responders to treatment.

Biography
A board-certified physician, Daniel Knecht, M.D., M.B.A., serves as Chief Medical Officer and Senior Vice President of Emblem Health. In this role, he leads the organization’s overall clinical strategy which includes innovating care models, improving health outcomes and enhancing the value of care provided to approximately three million New Yorkers. Dr. Knecht holds an MD/MBA from Weill Cornell Medical College and a BA in Biochemistry and Molecular Biology from Dartmouth College. A Fullbright Scholar and Modern Healthcare 40 Under 40 honoree, he is an active board member of CUNY School of Public Health Foundation, committed to building a future pipeline of outstanding talent for our health care system.

Biography
Michael A. Pfeffer, MD, FACP serves as Chief Information and Digital Officer and Associate Dean for Stanford Health Care and Stanford University School of Medicine. Michael oversees Technology and Digital Solutions (TDS), responsible for providing world class technology solutions to Stanford Health Care and School of Medicine, enabling new opportunities for groundbreaking research, teaching, and compassionate care across two hospitals and over 150 clinics. TDS supports Stanford Medicines mission to improve human health through discovery and care and strategic priorities to be value focused, digitally driven, and uniquely Stanford. Michael is a Clinical Professor in the Department of Medicine and Division of Hospital Medicine with a joint appointment in the center for Biomedical Research (BMIR) in Stanford University School of Medicine.

Biography
Peter Hulick, MD, a clinical geneticist and chair of personalized medicine at Endeavor Health, helps patients understand how genomic information can inform care and improve health outcomes. With a career rooted in genetics since high school, he works to integrate genomic data into everyday decision-making for patients and clinicians. Dr. Hulick focuses on risk assessment, early detection and treatment guidance by combining science, patient context and team collaboration. He also leads efforts to make genomic care more accessible across the health system.

Biography
Victor J. Dzau is a physician-scientist and global leader whose career bridges discovery, health system leadership, and national medicine policy. His cardiovascular research on the renin-angiotensin system helped shape modern understanding of vascular disease and contributed to the development and use of lifesaving ACE inhibitor therapies. As president of the National Academy of Medicine, he led major initiatives in precision health, human genome editing, clinician well-being, pandemic preparedness, global health, and equitable innovation. He previously served as Chancellor for Health Affairs at Duke University and President and CEO of Duke University Health System, and held senior academic leadership roles at Stanford and Harvard. In 2026, Dzau returned to Duke as James B. Duke Distinguished Professor of Medicine, Chancellor Emeritus for Health Affairs, and Director of the Mandel Center for Hypertension and Atherosclerosis. His career reflects the PMWC mission: turning science into systems that improve lives at scale worldwide today everywhere.

Biography
Dr. Paz has served as an executive and board member across providers, payers, and med-tech. He was EVPCMO of CVS Health Aetna; ChancellorCEO of Ohio State Wexner Medical Center; and CEO of Penn State Health and Stony Brook Univ Medicine. He sits on the boards of Envision Healthcare and Research America and previously served on Select Medical, USPI, Vyteris, and seven health-system boards. He advises Curai Health and previously advised Johnson Johnson and USPI. He has served on committees of the National Academy of Medicine and the National Academies. A former medical school dean and investigator in sepsis, A RDS, and medical devices, he has authored over 100 publications. Dr. Paz earned his BA and MD at the University of Rochester and an MS in life science engineering at Tufts, trained at Northwestern, and completed fellowships at Johns Hopkins in pulmonary and critical care and in environmental health sciences.

Biography
As Chairman of Oracle Health, David Feinberg, MD, is committed to making healthcare more accessible, affordable, and equitable. His work advances thought leadership and strategy related to unleashing the healing power of data through an open and connected healthcare ecosystem. Previously, David served as president and CEO of Cerner, now Oracle Health, where he led teams focused on delivering tools and technology to improve the patient and caregiver experience. David built his early career as a pediatric psychiatrist around helping children and families. He served as president and CEO of both UCLA Health and Geisinger Health prior to assuming leadership of Google Health in early 2019. He earned his MD from Chicago Medical School in 1989, finishing at the top of his class and is a member of the Alpha Omega Alpha Medical Honor Society. He also holds an economics degree from the University of California-Berkeley and an MBA from Pepperdine University.

Biography
Dr. Montalto is an industry leader in translational and precision medicine, digital pathology and AI for biomarker discovery. Prior to Amgen, Dr. Montalto was the Chief Scientific Officer of PathAI, and Vice President of Translational Sciences at Bristol Myers Squibb. He has led teams to invent, develop and launch digital pathology, spatial multiplexing and AI-powered software applications as well as flagship biomarker testing programs such as PharmDx 28-8 (PD-L1/Agilent) for Opdivo, Yervoy and Opdualag. Dr. Montalto serves on the Executive Committee of FNIH Biomarker Consortium, the editorial board of the Journal of AI in Precision Oncology and is a member of the Friends of Cancer Research Digital Pathology Working Group. He is the former President and board member of the Digital Pathology Association, has served as a scientific advisor to various multinational and start-up companies, holds 10 U.S. patents and has authored over 100 publications.

Biography
Driving innovation in precision medicine, implementation science, and health system transformation, as well as basic, translational and clinical research. Passionate about defining value and shifting healthcare from reactive to proactive. Skilled in forging strategic partnerships across healthcare, academia, and industry. Led multi-million-dollar initiatives, established and scaled research centers, clinics, and programs. Successfully secured tens of millions in competitive funding, with impactful publications and invited lectures across six continents to advance personalized, proactive, value-based care and research.

Biography
Tamara Syrek Jensen is a nationally recognized health policy leader and former Director of CMS’s Coverage and Analysis Group (CAG), where she led national coverage policy for devices, drugs, biologics, and preventive services affecting more than 65 million Medicare beneficiaries. She was named CMS Executive of the Year in 2022 for her leadership in expanding patient access to innovation. At Rubrum Advising, she focuses on coverage and payment strategy for medical technologies, helping clients align clinical evidence, FDA pathways, and payer requirements from early development through launch.

Biography
Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor’s degree in anthropology and global health from Williams College and a master’s degree in social work from Boston College. She lives in San Diego.

Biography
Gary Marchant is a Regent's Professor of Law and director of the Center for Law, Science and Innovation at ASU. His research focuses on the legal aspects of genomics, personalized medicine, and governance of emerging technologies like AI and biotechnology. He is a frequent speaker at national and international forums, Marchant has authored over 200 publications on emerging technologies. He has contributed to seven National Academy of Sciences committees, led numerous grants, and organized academic conferences on law and science. He is a lifetime member of the American Law Institute and a Fellow of the American Association for the Advancement of Science.Education: J.D., Harvard Law School (1990); M.P.P., Kennedy School of Government, Harvard University (1990); Ph.D. in Genetics, University of British Columbia (1986); B.Sc., University of British Columbia (1980)

Biography
Constance “Connie” Lehman, MD PHD is Founder and CEO of Clairity, Inc. She is Professor of Radiology at Harvard Medical School, breast imaging specialist, Founder and co-Director of the Breast Imaging Research Center at the Massachusetts General Brigham health system (on leave). Collectively, her research leverages advanced tools of Artificial Intelligence to promote targeted screening strategies and more effective methods of risk reduction and cancer prevention at the individual level. She earned her MD and PhD from Yale University after graduating Phi Beta Kappa from Duke University. She was named one of Forbes’ 50 Over 50: Innovators for her leadership in science and technology and named to TIME’s 2026 TIME100 Health List of the World’s Most Influential Leaders in Health.

Biography

Biography
Dr. Paz has served as an executive and board member across providers, payers, and med-tech. He was EVPCMO of CVS Health Aetna; ChancellorCEO of Ohio State Wexner Medical Center; and CEO of Penn State Health and Stony Brook Univ Medicine. He sits on the boards of Envision Healthcare and Research America and previously served on Select Medical, USPI, Vyteris, and seven health-system boards. He advises Curai Health and previously advised Johnson Johnson and USPI. He has served on committees of the National Academy of Medicine and the National Academies. A former medical school dean and investigator in sepsis, A RDS, and medical devices, he has authored over 100 publications. Dr. Paz earned his BA and MD at the University of Rochester and an MS in life science engineering at Tufts, trained at Northwestern, and completed fellowships at Johns Hopkins in pulmonary and critical care and in environmental health sciences.

Biography

Biography